OrionRx's Don Anderson, Pharm.D., says a GLP-1 access model built around mandatory wellness coaching resulted in a six-point ...
Yellow eyelid Xanthelasma signals hidden high cholesterol and cardiovascular disease risk, tripling heart attack and stroke ...
Relapse accumulated to 20% by 12 months, and each one-point increase in maladaptive coping score conferred ~6% higher ...
Poh says there is no single algorithm that applies to the treatment for patients with relapse or refractory follicular ...
More treatment doesn't automatically mean better treatment, Poh stresses, and the combinations that can improve ...
GLP-1 therapies continue to materially influence drug spend, with 2025 overall trend at 8.4% versus 7.9% excluding GLP-1s, ...
OrionRx's Don Anderson, Pharm.D., says drugs filled outside a member’s pharmacy benefit could result in excessive and ...
Optum Rx's automated prior authorization tool, PreCheck Prior Authorization, is automating almost two-thirds of approved ...
OrionRx's Don Anderson, Pharm.D., outlines near-term and long-term fixes for the blind spots created when members buy ...
Judi Health and the group purchasing organization Employers Health have teamed up to launch StarkRx, a modular, cost-plus pharmacy benefit solution. Judi Health’s PBM, Judi Rx, will provide the ...
FDA expands accelerated approval of oral sevabertinib for first-line HER2-mutant lung cancer, offering targeted treatment with strong response rates versus standard chemotherapy.
As PBMs plan for 2028 rollout of the PBM transparency provisions of the Consolidated Appropriations Act of 2026 (CAA 2026) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results